关注
Sejin Oh
Sejin Oh
Theragen Bio
在 theragenbio.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Selective cytotoxicity of the NAMPT inhibitor FK866 toward gastric cancer cells with markers of the epithelial-mesenchymal transition, due to loss of NAPRT
J Lee, H Kim, JE Lee, SJ Shin, S Oh, G Kwon, H Kim, YY Choi, MA White, ...
Gastroenterology 155 (3), 799-814. e13, 2018
992018
Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
S Oh, J Yeom, HJ Cho, JH Kim, SJ Yoon, H Kim, JK Sa, S Ju, H Lee, ...
Nature communications 11 (1), 3288, 2020
552020
Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer
Y Lee, CE Lee, S Oh, H Kim, J Lee, SB Kim, HS Kim
Cancers 12 (6), 1418, 2020
202020
Multi-layered proteogenomic analysis unravels cancer metastasis directed by MMP-2 and focal adhesion kinase signaling
Y Kwon, SJ Park, BT Nguyen, MJ Kim, S Oh, H Lee, N Park, HS Kim, ...
Scientific Reports 11 (1), 17130, 2021
142021
Emerging power of proteomics for delineation of intrinsic tumor subtypes and resistance mechanisms to anti-cancer therapies
S Oh, HS Kim
Expert Review of Proteomics 13 (10), 929-939, 2016
22016
系统目前无法执行此操作,请稍后再试。
文章 1–5